Delineating Ebola entry

Science

Volumn 347, Issue 6225, 2015, Pages 947-948

  Falzarano, Darryl ^a   Feldmann, Heinz ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CALCIUM CHANNEL L TYPE; SMALL INTERFERING RNA; VIRUS FUSION INHIBITOR; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; TPCN1 PROTEIN, HUMAN; TPCN2 PROTEIN, HUMAN;

CALCIUM; DISEASE INCIDENCE; ENZYME ACTIVITY; GENOME; GERM CELL; VIRAL DISEASE; VIRUS;

CALCIUM CELL LEVEL; CALCIUM SIGNALING; CLINICAL TRIAL (TOPIC); EBOLA VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS CONCENTRATION; VIRUS ENTRY; VIRUS GENOME; ANIMAL; DRUG EFFECTS; FEMALE; HEMORRHAGIC FEVER, EBOLA; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY;

ANIMALS; ANTIVIRAL AGENTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; MOLECULAR TARGETED THERAPY; VIRUS INTERNALIZATION;

EID: 84923886278     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaa8121     Document Type: Review

References (10)

1. Y. Sakurai et al., Science 347, 995 (2015).
2. C. L. Hunt, N. J. Lennemann, W. Maury, Viruses 4, 258 (2012).
3. M. F. Saeed, A. A. Kolokoltsov, T. Albrecht, R. A. Davey, PLOS Pathog. 6, e1001110 (2010).
4. A. Nanbo et al., PLOS Pathog. 6, e1001121 (2010).
5. K. Chandran, N. J. Sullivan, U. Felbor, S. P. Whelan, J. M. Cunningham, Science 308, 1643 (2005).
6. J. E. Carette et al., Nature 477, 340 (2011).
7. M. Côté et al., Nature 477, 344 (2011).
8. A. A. Kolokoltsov, M. F. Saeed, A. N. Freiberg, M. R. Holbrook, R. A. Davey, Drug Dev. Res. 70, 255 (2009).
9. X. Qiu et al., Nature 514, 47 (2014).
10. E. Picazo, F. Giordanetto, Drug Discov. Today 10.1016/j. drudis.2014.12.010 (2014).